Search Browse Earnings

Alaunos Therapeutics, Inc. — SlamSEC

Alaunos Therapeutics, Inc.

Nasdaq:TCRT

Pharmaceutical Preparations·FORT LAUDERDALE, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$5,000

-99.8% YoY

FY 2024

Adj. EBITDA

-$33.8M

-676100.0% margin

FY 2024

Net Income

-$35.1M

-702800.0% margin

FY 2024

EPS (Diluted)

-$21.97

FY 2024

Stock Price

$3.49

-3.3%

2026-03-10

52W Range

$1.31 – $6.20

P/E Ratio

-0.2x

Market Cap

$7.8M

Cash

$6.1M

FY 2024

Total Debt

—

Net Cash

$6.1M

FY 2024

Enterprise Value

$1.7M

Debt / EBITDA

0.2x

FY 2024

EV / EBITDA

-0.1x

Employees

—